Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 4/2017

01-04-2017 | Original Paper

Changes in Substance Use Symptoms Across Adolescence in Youth Perinatally Infected with HIV

Authors: M. Mutumba, K. S. Elkington, J. A. Bauermeister, A. Bucek, C. Dolezal, C. S. Leu, C. A. Mellins

Published in: AIDS and Behavior | Issue 4/2017

Login to get access

Abstract

The paper utilizes data collected at three time points in a longitudinal study of perinatally HIV-infected (PHIV+) and a comparison group of perinatally exposed but HIV-uninfected (PHEU) youths in the United States (N = 325). Using growth curve modeling, the paper examines changes in substance use symptoms among PHIV+ and PHEU youths as they transition through adolescence, and assesses the individual and contextual factors associated with the rate of change in substance use symptoms. Findings indicate that substance use symptoms increased over time among PHIV+ youths, but not among PHEU youths. The rate of change in these symptoms was positively associated with an increasing number of negative life events. Study findings underscore the need for early, targeted interventions for PHIV+ youths, and interventions to reduce adversities and their deleterious effects in vulnerable populations.
Literature
1.
Anglemyer A, Horvath T, Rutherford G. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. JAMA. 2013;310(15):1619–20.CrossRefPubMed
2.
3.
Tanser F, Bärnighausen T, Grapsa E, Zaidi J, Newell M-L. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339(6122):966–71.CrossRefPubMedPubMedCentral
4.
Bachanas PJ, Morris MK, Lewis-Gess JK, et al. Psychological adjustment, substance use, HIV knowledge, and risky sexual behavior in at-risk minority females: developmental differences during adolescence. J Pediatr Psychol. 2002;27(4):373–84.CrossRefPubMed
5.
Elkington KS, Bauermeister JA, Santamaria EK, Dolezal C, Mellins CA. Substance use and the development of sexual risk behaviors in youth perinatally exposed to HIV. J Pediatr Psychol. 2015;40(4):442–54.CrossRefPubMed
6.
Tapert SF, Aarons GA, Sedlar GR, Brown SA. Adolescent substance use and sexual risk-taking behavior. J Adolesc Health. 2001;28(3):181–9.CrossRefPubMed
7.
Elkington KS, Bauermeister JA, Brackis-Cott E, Dolezal C, Mellins CA. Substance use and sexual risk behaviors in perinatally human immunodeficiency virus-exposed youth: roles of caregivers, peers and HIV status. J Adolesc Health. 2009;45(2):133–41.CrossRefPubMedPubMedCentral
8.
Kapetanovic S, Wiegand RE, Dominguez K, et al. Associations of medically documented psychiatric diagnoses and risky health behaviors in highly active antiretroviral therapy-experienced perinatally HIV-infected youth. AIDS Patient Care STDs. 2011;25(8):493–501.CrossRefPubMedPubMedCentral
9.
Conner LC, Wiener J, Lewis JV, et al. Prevalence and predictors of drug use among adolescents with HIV infection acquired perinatally or later in life. AIDS Behav. 2013;17(3):976–86.CrossRefPubMed
10.
Mellins CA, Brackis-Cott E, Leu CS, et al. Rates and types of psychiatric disorders in perinatally human immunodeficiency virus-infected youth and seroreverters. J Child Psychol Psychiatry. 2009;50(9):1131–8.CrossRefPubMedPubMedCentral
11.
Williams PL, Leister E, Chernoff M, et al. Substance use and its association with psychiatric symptoms in perinatally HIV-infected and HIV-affected adolescents. AIDS Behav. 2010;14(5):1072–82.CrossRefPubMedPubMedCentral
12.
MacDonell K, Naar-King S, Huszti H, Belzer M. Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV. AIDS Behav. 2013;17(1):86–93.CrossRefPubMedPubMedCentral
13.
Rao D, Kekwaletswe T, Hosek S, Martinez J, Rodriguez F. Stigma and social barriers to medication adherence with urban youth living with HIV. AIDS Care. 2007;19(1):28–33.CrossRefPubMed
14.
Naar-King S, Templin T, Wright K, Frey M, Parsons JT, Lam P. Psychosocial factors and medication adherence in HIV-positive youth. AIDS Patient Care STDs. 2006;20(1):44–7.CrossRefPubMed
15.
Gardner EM, Burman WJ, Steiner JF, Anderson PL, Bangsberg DR. Antiretroviral medication adherence and the development of class-specific antiretroviral resistance. AIDS. 2009;23(9):1035.CrossRefPubMedPubMedCentral
16.
Wiener LS, Battles HB, Wood LV. A longitudinal study of adolescents with perinatally or transfusion acquired HIV infection: sexual knowledge, risk reduction self-efficacy and sexual behavior. AIDS Behav. 2007;11(3):471–8.CrossRefPubMedPubMedCentral
17.
Koenig LJ, Pals SL, Chandwani S, et al. Sexual transmission risk behavior of adolescents with HIV acquired perinatally or through risky behaviors. J Acquir Immune Defic Syndr. 2010;55(3):380–90.CrossRefPubMed
18.
Nugent NR, Brown LK, Belzer M, Harper GW, Nachman S, Naar-King S. Youth living with HIV and problem substance use: elevated distress is associated with nonadherence and sexual risk. J Int Assoc Physicians AIDS Care. 2010;9:113–5.CrossRef
19.
Alperen J, Brummel S, Tassiopoulos K, et al. Prevalence of and risk factors for substance use among perinatally human immunodeficiency virus-infected and perinatally exposed but uninfected youth. J Adolesc Health. 2014;54(3):341–9.CrossRefPubMed
20.
Mellins CA, Tassiopoulos K, Malee K, et al. Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS patient care STDs. 2011;25(7):413–22.CrossRefPubMedPubMedCentral
21.
Mellins CA, Elkington KS, Leu C-S, et al. Prevalence and change in psychiatric disorders among perinatally HIV-infected and HIV-exposed youth. AIDS Care. 2012;24(8):953–62.CrossRefPubMedPubMedCentral
22.
23.
Merikangas KR, J-p He, Burstein M, et al. Lifetime prevalence of mental disorders in US adolescents: results from the National Comorbidity Survey Replication-Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010;49(10):980–9.CrossRefPubMedPubMedCentral
24.
Centers for Disease Control Prevention. Racial/ethnic disparities among children with diagnoses of perinatal HIV infection-34 states, 2004-2007. MMWR. 2010;59(4):97.
25.
Centers for Disease Control Prevention. HIV Surveillance—United States, 1981–2008. MMWR. 2011;60(21):689–93.
26.
Denning P, DiNenno E. Communities in crisis: is there a generalized HIV epidemic in impoverished urban areas of the United States. In: Paper presented at: XVIII international AIDS conference, July 18–23, 2010; Vienna, Australia; Abstract WEPDD103.
27.
Dube SR, Miller JW, Brown DW, et al. Adverse childhood experiences and the association with ever using alcohol and initiating alcohol use during adolescence. J Adolesc Health. 2006;38(4):444.e1–10.CrossRef
28.
29.
Compas BE, Banez GA, Malcarne V, Worsham N. Perceived control and coping with stress: a developmental perspective. J Soc Issues. 1991;47(4):23–34.CrossRef
30.
Clarke AT. Coping with interpersonal stress and psychosocial health among children and adolescents: a meta-analysis. J Youth Adolesc. 2006;35(1):10–23.CrossRef
31.
Mellins CA, Brackis-Cott E, Dolezal C, Leu CS, Valentin C, Meyer-Bahlburg HF. Mental health of early adolescents from high-risk neighborhoods: the role of maternal HIV and other contextual, self-regulation, and family factors. J Pediatr Psychol. 2008;33(10):1065–75.CrossRefPubMedPubMedCentral
32.
Mellins CA, Brackis-Cott E, Dolezal C, Abrams EJ. The role of psychosocial and family factors in adherence to antiretroviral treatment in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2004;23(11):1035–41.CrossRefPubMed
33.
Murphy DA, Moscicki AB, Vermund SH, Muenz LR. Network AMHAR. Psychological distress among HIV+ adolescents in the REACH study: effects of life stress, social support, and coping. J Adolesc Health. 2000;27(6):391–8.CrossRefPubMed
34.
Malee KM, Tassiopoulos K, Huo Y, et al. Mental health functioning among children and adolescents with perinatal HIV infection and perinatal HIV exposure. AIDS Care. 2011;23(12):1533–44.CrossRefPubMedPubMedCentral
35.
Scheier LM, Botvin GJ, Miller NL. Life events, neighborhood stress, psychosocial functioning, and alcohol use among urban minority youth. J Child Adolesc Subst Abus. 2000;9(1):19–50.CrossRef
36.
Keyes KM, Hatzenbuehler ML, Hasin DS. Stressful life experiences, alcohol consumption, and alcohol use disorders: the epidemiologic evidence for four main types of stressors. Psychopharmacology. 2011;218(1):1–17.CrossRefPubMedPubMedCentral
37.
Fielden SJ, Sheckter L, Chapman GE, et al. Growing up: perspectives of children, families and service providers regarding the needs of older children with perinatally-acquired HIV. AIDS Care. 2006;18(8):1050–3.CrossRefPubMed
38.
Mellins CA, Malee KM. Understanding the mental health of youth living with perinatal HIV infection: lessons learned and current challenges. J Int AIDS Soc. 2013;16(1):18593.PubMedPubMedCentral
39.
Brown SA, Tomlinson K, Winward J. Substance use disorders in adolescence. In: Beauchaine TP, Hinshaw SP, editors. Child and adoelscent psychopathology. 2nd ed. Hoboken: Wiley; 2013. p. 489–510.
40.
Aarons GA, Brown SA, Hough RL, Garland AF, Wood PA. Prevalence of adolescent substance use disorders across five sectors of care. J Am Acad Child Adolesc Psychiatry. 2001;40(4):419–26.CrossRefPubMed
41.
42.
Preciado J, Henry M. Linguistic barriers in health education and services. In: Garcia JG, Zea MC, editors. Psychological interventions and research with Latino populations, Chapter 13. Boston: Allyn and Bacon; 1997. p. 235–54.
43.
Shaffer D, Fisher P, Lucas CP, Dulcan MK, Schwab-Stone ME. NIMH diagnostic interview schedule for children version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses. J Am Acad Child Adolesc Psychiatry. 2000;39(1):28–38.CrossRefPubMed
44.
American Psychological Association A. Diagnostic and statistical manual of mental disorders: DSM-IV: American Psychiatric Association. Washington DC: American Psychiatric Press; 1994.
45.
Rosenbaum JE. Truth or consequences: the intertemporal consistency of adolescent self-report on the Youth Risk Behavior Survey. Am J Epidemiol. 2009;169(11):1388–97.CrossRefPubMedPubMedCentral
46.
Williams RJ, McDermitt DR, Bertrand LD, Davis RM. Parental awareness of adolescent substance use. Addict Behav. 2003;28(4):803–9.CrossRefPubMed
47.
Beck AT. Beck depression inventory. San Antonio: The Psychological Association; 1987.
48.
Mellins CA, Havens J, Kang E. Child psychiatry service for children and families affected by the HIV epidemic. In: Paper presented at: IX International AIDS Conference, Berlin, Germany 1993.
49.
Ewart CK, Suchday S. Discovering how urban poverty and violence affect health: development and validation of a neighborhood stress index. Health Psychol. 2002;21(3):254.CrossRefPubMed
50.
Wyman PA, Cowen EL, Work WC, Kerley JH. The role of children’s future expectations in self-system functioning and adjustment to life stress: a prospective study of urban at-risk children. Dev Psychopathol. 1993;5(04):649–61.CrossRef
51.
Seginer R. Future orientation in times of threat and challenge: how resilient adolescents construct their future. Int J Behav Dev. 2008;32(4):272–82.CrossRef
52.
Aspinwall LG. The psychology of future-oriented thinking: from achievement to proactive coping, adaptation, and aging. Motiv Emot. 2005;29(4):203–35.CrossRef
53.
Seiffge-Krenke I, Aunola K, Nurmi JE. Changes in stress perception and coping during adolescence: the role of situational and personal factors. Child Dev. 2009;80(1):259–79.CrossRefPubMed
54.
Johnson LD, O’Malley P, Bachman J. National survey results on drug use from the monitoring the future study, 1975-1997. Rockville: National Institute on Drug Abuse; 1993.
55.
Raudenbush SW, Bryk AS. Hierarchical linear models: applications and data analysis methods, vol. 1. New York: Sage; 2002.
56.
57.
Barnes GM, Welte JW, Hoffman JH. Relationship of alcohol use to delinquency and illicit drug use in adolescents: gender, age, and racial/ethnic differences. J Drug Issues. 2002;32(1):153–78.CrossRef
58.
Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. The Lancet. 2004;363(9421):1579–88.CrossRef
59.
Suris JC, Parera N. Sex, drugs and chronic illness: health behaviours among chronically ill youth. Eur J Pub Health. 2005;15(5):484–8.CrossRef
60.
King G, Delaronde SR, Dinoi R, Forsberg AD. Committee HBIEP. Substance use, coping, and safer sex practices among adolescents with hemophilia and human immunodeficiency virus. J Adolesc Health. 1996;18(6):435–41.CrossRefPubMed
61.
Nation M, Heflinger CA. Risk factors for serious alcohol and drug use: the role of psychosocial variables in predicting the frequency of substance use among adolescents. Am J Drug Alcohol Abus. 2006;32(3):415–33.CrossRef
62.
Low NC, Dugas E, O’Loughlin E, et al. Common stressful life events and difficulties are associated with mental health symptoms and substance use in young adolescents. BMC Psychiatry. 2012;12(1):116.CrossRefPubMedPubMedCentral
63.
Windle M, Mun EY, Windle RC. Adolescent-to-young adulthood heavy drinking trajectories and their prospective predictors. J Stud Alcohol. 2005;66(3):313–22.CrossRefPubMed
64.
Sinha R. How does stress increase risk of drug abuse and relapse? Psychopharmacology. 2001;158(4):343–59.CrossRefPubMed
65.
Fishbein DH, Herman-Stahl M, Eldreth D, et al. Mediators of the stress–substance–use relationship in urban male adolescents. Prev Sci. 2006;7(2):113–26.CrossRefPubMed
66.
Sullivan TN, Farrell AD, Kliewer W. Peer victimization in early adolescence: association between physical and relational victimization and drug use, aggression, and delinquent behaviors among urban middle school students. Dev Psychopathol. 2006;18(01):119–37.CrossRefPubMed
67.
Radliff KM, Wheaton JE, Robinson K, Morris J. Illuminating the relationship between bullying and substance use among middle and high school youth. Addict Behav. 2012;37(4):569–72.CrossRefPubMed
68.
Rhodes JE, Jason LA. A social stress model of substance abuse. J Consult Clin Psychol. 1990;58(4):395.CrossRefPubMed
69.
Sharer L, Gendelman H, Grant I, Everall I, Lipton S, Swindells S. Neuropathological aspects of HIV-1 infection in children. Neurol AIDS. 2005:659–65.
70.
Gutiérrez F, Navarro A, Padilla S, et al. Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring. Clin Infect Dis. 2005;41(11):1648–53.CrossRefPubMed
71.
Munoz-Moreno JA, Fumaz CR, Ferrer MJ, et al. Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review. AIDS Rev. 2009;11(2):103–9.PubMed
72.
Lochet P, Peyriere H, Lotthe A, Mauboussin J, Delmas B, Reynes J. Long-term assessment of neuropsychiatric adverse reactions associated with efavirenz. HIV Med. 2003;4(1):62–6.CrossRefPubMed
73.
Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279(24):1977–83.CrossRefPubMed
74.
Wheeler WH, Ziebell RA, Zabina H, et al. Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, US–2006. AIDS. 2010;24(8):1203–12.CrossRefPubMed
75.
Murphy DA, Chen X, Naar-King S. Parsons for the adolescent trials network JT. Alcohol and marijuana use outcomes in the healthy choices motivational interviewing intervention for HIV-positive youth. AIDS Patient Care STDs. 2012;26(2):95–100.CrossRefPubMedPubMedCentral
76.
Lynskey MT, Fergusson DM, Horwood LJ. The origins of the correlations between tobacco, alcohol, and cannabis use during adolescence. J Child Psychol Psychiatry. 1998;39(07):995–1005.CrossRefPubMed
77.
Patton GC, Coffey C, Carlin JB, Sawyer SM, Lynskey M. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction. 2005;100(10):1518–25.CrossRefPubMed
78.
Degenhardt L, Hall W, Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction. 2001;96(11):1603–14.CrossRefPubMed
79.
Degenhardt L, Hall W. The relationship between tobacco use, substance-use disorders and mental health: results from the national survey of mental health and well-being. Nicot Tob Res. 2001;3(3):225–34.CrossRef
80.
Mitchell SG, Gryczynski J, O’Grady KE, Schwartz RP. SBIRT for adolescent drug and alcohol use: current status and future directions. J Subst Abus Treat. 2013;44(5):463–72.CrossRef
Metadata
Title
Changes in Substance Use Symptoms Across Adolescence in Youth Perinatally Infected with HIV
Authors
M. Mutumba
K. S. Elkington
J. A. Bauermeister
A. Bucek
C. Dolezal
C. S. Leu
C. A. Mellins
Publication date
01-04-2017
Publisher
Springer US
Published in
AIDS and Behavior / Issue 4/2017
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-016-1468-9

Other articles of this Issue 4/2017

AIDS and Behavior 4/2017 Go to the issue

Original Paper

Primary Care Physicians’ Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs

Brief Report

Correlates of Double Risk of HIV Acquisition and Transmission Among Women who Inject Drugs in St. Petersburg, Russia

Original Paper

The Influence of Neurocognitive Impairment, Depression, and Alcohol Use Disorders on Health-Related Quality of Life among Incarcerated, HIV-Infected, Opioid Dependent Malaysian Men: A Moderated Mediation Analysis

Editorial

Pence, Putin, Mbeki and Their HIV/AIDS-Related Crimes Against Humanity: Call for Social Justice and Behavioral Science Advocacy

Editorial

Preventing HIV and Hepatitis Infections Among People Who Inject Drugs: Leveraging an Indiana Outbreak Response to Break the Impasse

Original Paper

Social Network Influence on HIV Testing Among Urban Men in Tanzania
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits